FDA Authorizes Two Siemens Covid-19 Serology Tests

Aug. 1, 2020, 12:03 AM

The FDA authorized the first two Covid-19 serology tests produced by Siemens that display an estimated quantity of antibodies present in an individual’s blood.

  • The Adiva Centaur COV2G and Attelica COV2G tests estimate the quantity of a patient’s antibodies produced against infection with the virus that causes Covid-19
  • NOTE: July 29, FDA Authorizes New Quest Diagnostics Method for Covid-19 Tests

To contact the reporter on this story:
Malak Saleh in New York at msaleh28@bloomberg.net

To contact the editor responsible for this story:
Chakradhar Adusumilli at cadusumilli@bloomberg.net

© 2020 Bloomberg L.P. All rights reserved. Used with permission.

To read the full article log in.

Learn more about a Bloomberg Law subscription.